Abstract:Abstract Background Both gut microbiota and micro-RNAs (miRNAs) have been implicated in the pathogenesis of inflammatory bowel disease (IBD). We aimed to investigate the interactions between gut microbiota and miRNAs which are altered in murine colitis models and patients with IBD using multi-omics analysis. Methods Gut microbiota and miRNAs were analyzed in a mouse experiment (7 dextran sodium sulfate [DSS]-treated mice, 7 azoxymethane [AOM] and DSS-treated mice, and 6 controls) and a human experiment (10 patients with active Crohn’s disease, 10 patients with active ulcerative colitis [UC], and 8 healthy controls). DNA was extracted from mouse feces and human colonic tissues, and 16S rRNA gene sequencing was performed to evaluate changes in gut microbiota. miRNA expression levels were measured by microarray analysis from mouse and human colonic tissues. mRNA expression levels were examined by microarray analysis from colonic tissues of UC patients. Correlation and network analyses were performed to evaluate the interactions among gut microbiota, miRNAs and mRNAs. Results Principal coordinate analysis showed distinct gut microbiota composition and miRNA expressions among the groups in the mouse and human experiments. Also, comparative analysis showed many miRNAs differentially expressed and many bacterial amplicon sequence variants (ASVs) differentially identified among the groups. Spearman correlation rank test and network analysis revealed multiple correlations and interactions among specific miRNAs and bacterial ASVs. In UC patients, genes associated with functional categories in biological process, such as positive regulation of cytokine production, cytokine-mediated signaling pathway, cell adhesion, positive regulation of response to external stimulus, and leukocyte migration were upregulated than healthy controls. mRNAs in UC patients also showed multiple correlations and interactions with specific miRNAs and bacterial ASVs. Conclusion Gut microbiota composition and miRNA expressions were distinctly altered in patients with IBD and murine colitis models. Specific miRNAs were associated with specific bacterial ASVs and mRNAs, suggesting the interactions among miRNAs, gut microbiota and mRNAs in the pathogenesis of IBD. Our data imply that global complicated interactions between gut microbiota and miRNAs, rather than specific individual microbiota-miRNA interaction, might play more important role in IBD.

Human-derived microRNA 21 regulates indole and L-tryptophan biosynthesis transcripts in a prominent gut symbiont

Fecal let-7b and miR-21 directly modulate the intestinal microbiota, driving chronic inflammation

Divergent Influence Of Microrna-21 Deletion On Murine Colitis Phenotypes

Gut microbiota dysbiosis deteriorates immunoregulatory effects of tryptophan via colonic indole and LBP/HTR2B-mediated macrophage function

Discrete interplay of gut microbiota L-tryptophan metabolites in host biology and disease

A preliminary study on the effects of human microRNAs on gut microbiota

An (Anti)-Inflammatory Microbiota: Defining the Role in Inflammatory Bowel Disease?

MIR-21 regulating distribution of intestinal flora through TNF-α promotes progression of ulcerative colitis

Substrate availability and dietary fibre regulate metabolism of tryptophan by human gut microbes

MicroRNA-21 Plays Multiple Oncometabolic Roles in Colitis-Associated Carcinoma and Colorectal Cancer via the PI3K/AKT, STAT3, and PDCD4/TNF-α Signaling Pathways in Zebrafish

Bacterial indole-3-lactic acid affects epithelium-macrophage crosstalk to regulate intestinal homeostasis

The role of the indoles in microbiota-gut-brain axis and potential therapeutic targets: A focus on human neurological and neuropsychiatric diseases

Microbiota downregulates dendritic cell expression of miR-10a, which targets IL-12/IL-23p40.

Dietary fibre directs microbial tryptophan metabolism via metabolic interactions in the gut microbiota

Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor

The epithelial C15ORF48/miR-147-NDUFA4 axis is an essential regulator of gut inflammation, energy metabolism, and the microbiome

MicroRNA-21 Is a Versatile Regulator and Potential Treatment Target in Central Nervous System Disorders

miR-155 and miR-21 as Diagnostic and Therapeutic Biomarkers for Ulcerative Colitis: There Is Still a Long Way to Go

P913 Interactions between Intestinal Microbiota and micro-RNAs in Inflammatory Bowel Disease

Ruminococcus gnavus plays a pathogenic role in diarrhea-predominant irritable bowel syndrome by increasing serotonin biosynthesis

Gut Microbiota-Derived Tryptophan Metabolites Maintain Gut and Systemic Homeostasis